AzTrials
AzTrials

Inguinal HerniaNCT04171102

Neo-nervegenesis in Inguinal Hernia Implant ProFlor

A study testing ProFlor Hernia implant in people with Inguinal Hernia, run by University of Cagliari.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

The investigation is aimed at specifically demonstrating the ingrowth of newly formed nervous elements within a 3D dynamic responsive implant for inguinal hernia repair. Read more about this study

Who is it for?
Ages 18 years and older, men onlyHealthy volunteers can take part
Conditions the study is for
Inguinal Hernia
What is being tested?
ProFlor Hernia implant
Type of treatment
Medical device
Could I receive a placebo?
No, everyone receives an active treatment
How many people
15 participants
Where
No sites listed yet
Study dates
Jan 2013to Dec 2016
Phase
Interventional
Are there results?
Yes, posted in the registrySummary in the doctors' view

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 years and older
  • Men only
  • Healthy volunteers accepted
  • Adult, Older adult

Who may be able to join

  • Patients who underwent inguinal hernia repair with the prosthetic device named ProFlor
  • Patients undergoing recurrent inguinal hernia repair after primary repair with the prosthetic device named ProFlor
  • Patients undergoing surgical procedure in the groin area after inguinal hernia repair with the prosthetic device named ProFlor

Who cannot join

  • Patients who underwent inguinal hernia repair with conventional flat meshes

About this study

Official title: Neo-neurogenesis in 3D Dynamic Responsive Implant for Inguinal Hernia Repair PorFlor

The investigation is aimed at specifically demonstrating the ingrowth of newly formed nervous elements within a 3D dynamic responsive implant for inguinal hernia repair.

Read the detailed description

Biopsy specimen were excised at defined postoperative stages from patients who underwent hernia repair with the 3D prosthesis named ProFlor. Scope of the study was to determine the presence, quantity and quality of the neural ingrowth within the implant fabric. Histology revealed the presence of multiple nerve clusters that, starting from the early stage post-implantation, increased in number and degree of maturation. In the long term, neural elements assumed the typical aspect of normal nervous structures complete in all components. The development of highly specialized tissue such as nerves, together with other components of the abdominal wall already described in literature, seems to finalize a regenerative response. This kind of behavior, being the expected result from a device intended for the cure of inguinal hernia and its degenerative source, seems to be coherent with the pathogenesis of the disease.

Conditions
Inguinal Hernia
Being tested
ProFlor Hernia implant
Keywords
Hernia implants, Biologic response, Neo-nervegenesis, Regenerative scaffold
Medical subject headings
Hernia, Inguinal

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • ProFlor Hernia implantDevice

    Inguinal hernia repair

Study groups in NCT04171102
Study groupRoleWhat they receive
Short term post inguinal hernia repair wit ProFlorActive comparatorDetermining presence and level of maturation of nervous structures in the hernia implant named ProFlor at 3-5 weeks post implantation
Receives: Device: ProFlor Hernia implant
Mid term post inguinal hernia repair wit ProFlorActive comparatorDetermining presence and level of maturation of nervous structures in the hernia implant named ProFlor at 3-4 months post implantation
Receives: Device: ProFlor Hernia implant
Long term post inguinal hernia repair wit ProFlorActive comparatorDetermining presence and level of maturation of nervous structures in the hernia implant named ProFlor at 6-8 months post implantation
Receives: Device: ProFlor Hernia implant

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Ingrowth of Newly Formed Nervous Elements Within Hernia Implant ProFlor

    Post-operative assessment of neonervegenesis within hernia implant ProFlor at short, mid and long term post-implantation

    Measured: 3 weeks until 8 months post-implantation

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted20 Nov 2019
  2. Study startJan 2013
  3. Primary completionDec 2016
  4. Study completionDec 2016

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Non-randomised
Intervention model
Sequential
Masking
Single blind
Who is masked
Participant
Enrolment
15 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT04171102
Sponsor's protocol ID
Neo-nervegenesis in ProFlor
Status last verified
Jun 2020
First submitted
15 Nov 2019
Last updated
17 Jun 2020
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
Yes
Individual data sharing
Yes: Tissue specimen and histological records upon request

Publications

  • Amato G, Lo Monte AI, Cassata G, Damiano G, Romano G, Bussani R. A new prosthetic implant for inguinal hernia repair: its features in a porcine experimental model. Artif Organs. 2011 Aug;35(8):E181-90. doi: 10.1111/j.1525-1594.2011.01272.x. Epub 2011 Jul 13.

    PubMed 21752035
  • Amato G, Romano G, Agrusa A, Marasa S, Cocorullo G, Gulotta G, Goetze T, Puleio R. Biologic response of inguinal hernia prosthetics: a comparative study of conventional static meshes versus 3D dynamic implants. Artif Organs. 2015 Jan;39(1):E10-23. doi: 10.1111/aor.12416.

    PubMed 25626584
  • Amato G, Romano G, Puleio R, Agrusa A, Goetze T, Gulotta E, Gordini L, Erdas E, Calo P. Neomyogenesis in 3D Dynamic Responsive Prosthesis for Inguinal Hernia Repair. Artif Organs. 2018 Dec;42(12):1216-1223. doi: 10.1111/aor.13286. Epub 2018 Oct 14.

    PubMed 30318605
  • Amato G, Agrusa A, Puleio R, Calo P, Goetze T, Romano G. Neo-nervegenesis in 3D dynamic responsive implant for inguinal hernia repair. Qualitative study. Int J Surg. 2020 Apr;76:114-119. doi: 10.1016/j.ijsu.2020.02.046. Epub 2020 Mar 10.

    PubMed 32169570

Questions about this trial

What is this clinical trial studying?

A study testing ProFlor Hernia implant in people with Inguinal Hernia, run by University of Cagliari.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 3 inclusion and 1 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 17 Jun 2020. Status can change between updates, so confirm with the study contact before making plans.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

Yes. Results are posted in the registry (first posted 11 Jun 2020). A summary is in the For doctors view, and the full results are on ClinicalTrials.gov.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Ingrowth of Newly Formed Nervous Elements Within Hernia Implant ProFlor (time frame: 3 weeks until 8 months post-implantation). It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT04171102, which also lists 4 linked publications.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 17 Jun 2020.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in